FDA product code QAK: Non-Invasive Vagus Nerve Stimulator For Migraine Headache
QAK is the FDA product code for non-invasive vagus nerve stimulator for migraine headache. It is a Class II device, regulated under 21 CFR 882.5892 and reviewed by the Neurology panel. Devices under QAK reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
The device intended for non-invasive vagus nerve stimulation (nVNS) on the side of the neck to treat migraine headache.
Classification
| Field | Value |
|---|---|
| Device name | Non-Invasive Vagus Nerve Stimulator For Migraine Headache |
| Device class | Class II |
| Regulation | 21 CFR 882.5892 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
Recalls for QAK devices
FDA recall records list no recalls for product code QAK.
Frequently asked questions
What is FDA product code QAK?
QAK is the FDA product code for non-invasive vagus nerve stimulator for migraine headache. It is a Class II device, regulated under 21 CFR 882.5892 and reviewed by the Neurology panel.
What device class is QAK?
Class II, regulation 21 CFR 882.5892. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code QAK
- Run a recall and safety report across every QAK manufacturer
- Watch product code QAK for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times